Becton Dickinson Recalls Eclipse Hypodermic Needles Due to Safety Complaints
Becton Dickinson is issuing a Product Advisory for Eclipse Hypodermic Needles due to safety complaints regarding disengagement and needlestick injuries.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a medical device with reported needlestick injuries, which constitutes a risk of harm where injury has been reported but no fatalities or FDA Class I classification is present.
Plain-English summary
Becton Dickinson & Company is initiating a Product Advisory for the Eclipse Hypodermic Needle. This action is being taken in response to safety complaints that cover needle disengagement and needlestick injuries.
The recall involves 263 mm units of the Eclipse Hypodermic Needle. The distribution pattern for these units is listed as US Nationwide.
The source text does not specify specific actions for consumers or healthcare providers beyond the initiation of the Product Advisory. No specific dates, lot numbers, or additional distribution details are provided in the available text.
The recalled product
- Product
- Eclipse Hypodermic Needle
- Manufacturer
- Becton Dickinson & Company
- Affected units
- 263
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- N/A
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Becton Dickinson & Company
See all →- SevereBD Quincke spinal trays recalled over Huons bupivacaine quality issues
FDA (Devices) · 2026-06-10
- SevereBD Whitacre 24 gauge spinal trays recalled over bupivacaine quality issues
FDA (Devices) · 2026-06-10
- SevereBD Whitacre 22G spinal trays recalled in Huons bupivacaine sub-recall
FDA (Devices) · 2026-06-10
- SevereBD Whitacre spinal trays across nine catalog numbers recalled over bupivacaine
FDA (Devices) · 2026-06-10
- SevereBD spinal trays recalled as a sub-recall of Huons bupivacaine
FDA (Devices) · 2026-06-10
Same hazard · needlestick injury
See all →- HighMedline IV Catheter Kits Recalled Over Needle Retraction Issue
FDA (Devices) · 2025-07-09
- HighBD Insyte Autoguard IV Catheter Needles May Fail to Retract Properly
FDA (Devices) · 2023-12-06
- HighSafety Blood Collection Needles Recalled Due to Safety Mechanism Activation Difficulty
FDA (Devices) · 2021-11-17
- HighBD Nexiva IV Catheter Recall Due to Needle Shield Failure
FDA (Devices) · 2018-11-14
- SevereArrow International Recalls Access Kits Due to Needlestick Injury Risk
FDA (Devices) · 2017-06-14
Similar recalls
- HighBD Vacutainer Eclipse Blood Collection Needles Recalled for Missing Bevel
FDA (Devices) · 2019-11-06
- HighBD Precision Glide Needles Recalled for Hub Damage and Leakage
FDA (Devices) · 2017-12-13
- ModerateBD Stimex Insulated Needle Recall for Missing Contraindications
FDA (Devices) · 2021-02-03
- ModerateFDA Recalls Hypodermic Needles Due to Insufficient Sterility Documentation
FDA (Devices) · 2017-08-16
- HighBD SafetyGlide Injection Needle Recall Due to Sterility Assurance Issues
FDA (Devices) · 2017-07-26
- HighBD PrecisionGlide Needles Recalled Due to Blood Contamination
FDA (Devices) · 2020-12-23